DE60103685D1 - Behandlung von Poriomania - Google Patents
Behandlung von PoriomaniaInfo
- Publication number
- DE60103685D1 DE60103685D1 DE60103685T DE60103685T DE60103685D1 DE 60103685 D1 DE60103685 D1 DE 60103685D1 DE 60103685 T DE60103685 T DE 60103685T DE 60103685 T DE60103685 T DE 60103685T DE 60103685 D1 DE60103685 D1 DE 60103685D1
- Authority
- DE
- Germany
- Prior art keywords
- poriomania
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 206010036173 Poriomania Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000088453 | 2000-03-28 | ||
JP2000088453 | 2000-03-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60103685D1 true DE60103685D1 (de) | 2004-07-15 |
DE60103685T2 DE60103685T2 (de) | 2005-06-16 |
Family
ID=18604333
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60103685T Expired - Lifetime DE60103685T2 (de) | 2000-03-28 | 2001-03-28 | Behandlung von Poriomania |
Country Status (4)
Country | Link |
---|---|
US (1) | US6380176B2 (de) |
EP (1) | EP1138332B1 (de) |
CA (1) | CA2342435C (de) |
DE (1) | DE60103685T2 (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4438256B2 (ja) * | 2001-06-29 | 2010-03-24 | 味の素株式会社 | 動伴侶動物における問題行動を防止するための医薬組成物および方法 |
EP1452096A4 (de) * | 2001-11-29 | 2004-12-22 | Ajinomoto Kk | Geflügelmastverfahren |
JP2005132747A (ja) * | 2003-10-29 | 2005-05-26 | Ajinomoto Co Inc | 老齢伴侶動物の老化行動改善剤 |
US7824697B2 (en) | 2004-07-12 | 2010-11-02 | Board Of Regents, The University Of Texas System | High concentration baclofen preparations |
US8781491B2 (en) | 2007-03-02 | 2014-07-15 | Aegis Mobility, Inc. | Management of mobile device communication sessions to reduce user distraction |
US8224353B2 (en) | 2007-09-20 | 2012-07-17 | Aegis Mobility, Inc. | Disseminating targeted location-based content to mobile device users |
US20150258279A1 (en) | 2008-03-18 | 2015-09-17 | Mallinckrodt Llc | Intrathecal baclofen pharmaceutical dosage forms and related delivery system |
US8969414B2 (en) * | 2009-02-06 | 2015-03-03 | Mallinckrodt Llc | Intrathecal baclofen pharmaceutical dosage forms with fewer degradation products |
GB2571696B (en) | 2017-10-09 | 2020-05-27 | Compass Pathways Ltd | Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced |
CN113993522A (zh) | 2019-04-17 | 2022-01-28 | 指南针探路者有限公司 | 用赛洛西宾治疗焦虑障碍、头痛病症和进食障碍的方法 |
-
2001
- 2001-03-26 US US09/816,396 patent/US6380176B2/en not_active Expired - Fee Related
- 2001-03-28 CA CA002342435A patent/CA2342435C/en not_active Expired - Fee Related
- 2001-03-28 DE DE60103685T patent/DE60103685T2/de not_active Expired - Lifetime
- 2001-03-28 EP EP01107478A patent/EP1138332B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US6380176B2 (en) | 2002-04-30 |
CA2342435C (en) | 2007-05-08 |
US20010051618A1 (en) | 2001-12-13 |
CA2342435A1 (en) | 2001-09-28 |
EP1138332B1 (de) | 2004-06-09 |
EP1138332A1 (de) | 2001-10-04 |
DE60103685T2 (de) | 2005-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE323661T1 (de) | Behandlung von mineralischen stoffen | |
DE69925306D1 (de) | Behandlung von kohlenwasserstoffgas | |
DE60001421D1 (de) | Behandlung von abgas | |
DE69926385D1 (de) | Behandlung von geweben | |
DE60124302D1 (de) | Thiazolderivate zur behandlung von ppar-lierte krankheiten | |
ATE260332T1 (de) | Behandlung von textilien | |
DE60019195D1 (de) | Behandlung durch Ablation von Knochenmetastasen | |
DE60019556D1 (de) | 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit | |
ATE275145T1 (de) | Chinazolinderivate zur behandlung von tumoren | |
ATE538096T1 (de) | Pyridinon-derivate zur behandlung von arteriosklerose | |
DE60219292D1 (de) | Pyrazolderivate zur behandlung von hiv | |
DE60140516D1 (de) | Behandlung von fluorkohlenstoff- ausgangsmaterialien | |
ATE417602T1 (de) | Mittel zur behandlung von erkrankungen der speiseröhre | |
ATE265860T1 (de) | Impstoff zur behandlung von atherosclerosis | |
DE50214540D1 (de) | Stanz bei der behandlung von wunden | |
DE60019555D1 (de) | 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit | |
DE60136477D1 (de) | Retinoide zur behandlung von emphysem | |
DE60325353D1 (de) | Behandlung von mukositis | |
ATE298569T1 (de) | Virus behandlung | |
ATE273276T1 (de) | Cyclobutendion-derivate zur behandlung von artherosclerose | |
DE50105735D1 (de) | Chlorzoxazon zur behandlung von psoriasis | |
DE60103685D1 (de) | Behandlung von Poriomania | |
DE69932235D1 (de) | Behandlung von herzhypertrophie | |
DE60026821D1 (de) | Behandlung von bohrspülung | |
DE60110748D1 (de) | Behandlung von fluorkohlenstoff-beschickungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |